XNYS
ZEPP
Market cap55mUSD
Oct 08, Last price
3.84USD
1D
-0.52%
1Q
-28.09%
IPO
-91.56%
Name
Zepp Health Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.
Key people
Chief Financial Officer · since 2017
Hui Wang
Vice President of Health and Medical Business Group and General Manager of Beijing Operations · since 2014
Wang Huang
Chairman of the Board of Directors, Chief Executive Officer
Independent Director · since 2018
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||